Filter
1439
Filtered Results: 1439
Text search:
Ministry
of
Health,
Department
of
Drug
Administration
Featured
Recommendations
132
New Publications
496
Language
Document type
No document type
942
Guidelines
190
Studies & Reports
176
Manuals
62
Strategic & Response Plan
47
Training Material
15
Situation Updates
4
Fact sheets
3
Countries / Regions
India
125
Kenya
79
Nigeria
50
Ethiopia
50
Uganda
48
Tanzania
47
Myanmar / Burma
43
Nepal
39
Liberia
39
Ghana
36
Zambia
36
Western and Central Europe
32
Malawi
28
Sierra Leone
27
Global
26
Rwanda
24
Bangladesh
23
Latin America and the Carribbean
22
Eastern Europe
18
Ukraine
17
Africa
16
Namibia
15
Zimbabwe
14
Botswana
13
Cambodia
12
Lesotho
10
South–East Asia Region
10
South Africa
10
Mozambique
9
Eswatini/ Swaziland
8
Indonesia
7
Tajikistan
6
Philippines
6
Asia
6
South Sudan
6
Thailand
5
Cameroon
5
Senegal
5
East and Southern Africa
5
Russia
5
Georgia
5
Syria
4
Albania
4
Laos
4
Jordan
4
Congo, Democratic Republic of
4
Middle East and North Africa
4
Paraguay
4
Sudan
4
Pakistan
4
China
3
Burkina Faso
3
Haiti
3
Germany
3
Eastern Europe and Central Asia
3
Timor Leste/ East Timor
2
Iran
2
West and Central Africa
2
Sri Lanka
2
Poland
2
North Macedonia
1
Colombia
1
Serbia
1
Turkey
1
Benin
1
Gambia
1
Kazakhstan
1
Fiji
1
Singapore
1
Estonia
1
Kyrgyzstan
1
Afghanistan
1
Peru
1
Morocco
1
Qatar
1
Venezuela
1
Hungary
1
Saudi Arabia
1
Western Pacific Region
1
North America
1
Turkmenistan
1
Denmark
1
Maldives
1
Tunisia
1
Bolivia
1
Argentina
1
Lebanon
1
Vietnam
1
Papua New Guinea
1
Brazil
1
Moldova
1
Romania
1
Greece
1
Palestine
1
Mali
1
Angola
1
Libya
1
Bhutan
1
Iraq
1
Somalia
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
783
Clinical Guidelines
121
Public Health
58
Women & Child Health
46
Key Resources
43
Pharmacy & Technologies
15
Capacity Building
11
Toolboxes
TB
113
HIV
108
Mental Health
85
NTDs
74
AMR
68
Pharmacy
56
COVID-19
41
Rapid Response
38
Caregiver
31
Ebola & Marburg
17
Refugee
13
Conflict
12
Planetary Health
11
NCDs
10
Disability
8
Global Health Education
7
Health Financing Toolbox
6
Specific Hazards
5
Natural Hazards
5
Polio
4
Cholera
3
Social Ethics
3
Zika
3
Malaria
2
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
Indoor residual spraying (IRS) involves applying residual insecticide to potential vector resting sites on the interior surfaces of human dwellings or other buildings. The main aim of IRS is to kill vectors before they are able to transmit pathogens to humans. When carried out correctly, IRS has his...
Since 2000, concerted efforts by national programmes, supported by public–private partnerships, nongovernmental organizations, donors and academia under the auspices and coordination of the World Health Organization (WHO), have produced important achievements in the control of human African trypan...
These WHO guidelines which were updated in 2018, are valid for any country and suitable to local adaptations, and take account of the strength of available scientific evidence, the cost and resource implications, and patient values and preferences.
The 2018 edition of the guidelines includes the re...
Health ministries currently lack effective tools for monitoring and evaluation of schistosomiasis control programmes. Egg detection can be used, but the cost, challenges of obtaining samples, and the need for trained personnel and equipment limit the frequency of monitoring. The purpose of this TPP ...
Djibuti et al. BMC Public Health (2015) 15:427 DOI 10.1186/s12889-015-1760-z
The Committee discussed the implications for preparedness for smallpox-like events reflected by the ongoing COVID-19 pandemic. The Committee noted how quickly diagnostics and vaccines could be developed and deployed when resources and political will were abundant. This rapidity was also due to the f...
Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hepatitis B and C impact targets to demonstrate elimination, whilst highlighting challenges caused by hig...
The Global guidance framework for the responsible use of the life sciences: mitigating biorisks and governing dual-use research (the framework) aims to provide values and principles, tools and mechanisms to support Member States and key stakeholders to mitigate and prevent biorisks and govern dual-u...
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a...
ournal of Public Health in Africa 2021; volume 12:2009
The availability, prices and affordability of essential medicines in Malawi: A cross-sectional study
The Malawian government recently introduced cost-covering consultation fees for self-referral patients in tertiary public hospitals. Previously, patients received medicines free of charge in government-owned health facilities, but must pay elsewhere. Before the government implements a payment policy...
